Fatty Acids, Antibiotic Resistance, and Deoxyribonucleic Acid Homology Groups of Bradyrhizobium japonicum
LD Kuykendall, MA Roy, JJ O'neill… - … of Systematic and …, 1988 - microbiologyresearch.org
LD Kuykendall, MA Roy, JJ O'neill, TE Devine
International Journal of Systematic and Evolutionary …, 1988•microbiologyresearch.orgThe fatty acid compositions and multiple antibiotic resistance patterns of 32 strains of
Bradyrhizobium japonicum correlated with two major deoxyribonucleic acid homology
groups. In group I, the fatty acid composition was 1.3% 16: 1 cis9 acid, 3.6% 16: 1C acid,
8.8% 16: 0 acid, 1.2% 19: 0 cyclopropane acid, and 81.2% 18: 1 acid. Group II contained
0.5% 16: 1C acid, 11.1% 16: 0 acid, 0.8% 17: 0 cyclopropane acid, 24.7% 19: 0
cyclopropane acid, and 62.3% 18: 1 acid. Group I strains were susceptible to rifampin (500 …
Bradyrhizobium japonicum correlated with two major deoxyribonucleic acid homology
groups. In group I, the fatty acid composition was 1.3% 16: 1 cis9 acid, 3.6% 16: 1C acid,
8.8% 16: 0 acid, 1.2% 19: 0 cyclopropane acid, and 81.2% 18: 1 acid. Group II contained
0.5% 16: 1C acid, 11.1% 16: 0 acid, 0.8% 17: 0 cyclopropane acid, 24.7% 19: 0
cyclopropane acid, and 62.3% 18: 1 acid. Group I strains were susceptible to rifampin (500 …
The fatty acid compositions and multiple antibiotic resistance patterns of 32 strains of Bradyrhizobium japonicum correlated with two major deoxyribonucleic acid homology groups. In group I, the fatty acid composition was 1.3% 16:1 cis9 acid, 3.6% 16:1C acid, 8.8% 16:0 acid, 1.2% 19:0 cyclopropane acid, and 81.2% 18:1 acid. Group II contained 0.5% 16:1C acid, 11.1% 16:0 acid, 0.8% 17:0 cyclopropane acid, 24.7% 19:0 cyclopropane acid, and 62.3% 18:1 acid. Group I strains were susceptible to rifampin (500 μ g/ml), tetracycline (100 μ g/ml), streptomycin (100 μ /ml), chloramphenicol (500 μ g/ml), erythromycin (250 μ g/ml), carbenicillin (500 μ g/ml), and nalidixic acid (50 μ g/ml), whereas group II strains were resistant to these antibiotics. Both groups were resistant to trimethoprim (50 μ g/ml) and vancomycin (100 μ g/ml).
Microbiology Research